Cardiovascular Comorbidities of COPD: When Do they Occur and How are they Managed?

ISSN: 1875-6387 (Online)
ISSN: 1573-398X (Print)

Volume 13, 4 Issues, 2017

Download PDF Flyer

Current Respiratory Medicine Reviews

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Joseph Varon
The University of Texas Health Science Center
Houston, TX

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Cardiovascular Comorbidities of COPD: When Do they Occur and How are they Managed?

Current Respiratory Medicine Reviews, 9(6): 384-391.

Author(s): Angelos Angelakas, Charalambos Vlachopoulos, Nikolaos Ioakeimidis, Athanasios Aggelis, Konstantinos Aznaouridis and Christodoulos Stefanadis.

Affiliation: 1st Cardiology Department, Athens Medical School, Hippokration Hospital, 60, Vatatzi Street, 11473 Athens, Greece.


Chronic obstructive pulmonary disease (COPD) is highly prevalent worldwide. Its morbidity and mortality are increasing and it is predicted to be the third leading cause of death by 2020. COPD and cardiovascular disease (CVD) are chronic conditions that share many risk factors and a complex pathophysiology. Current literature has closely focused on the relationship between these two diseases and today COPD is considered to be an independent risk factor for CVD, which is the leading cause of death in approximately 50% of COPD patients. Coronary artery disease, congestive heart failure, pulmonary hypertension, cardiac arrhythmias, peripheral artery and cerebrovascular disease have been documented to present more frequently in COPD patients than in individuals without COPD. Moreover, despite the fact that the exact pathophysiologic mechanism linking COPD to CVD is not yet found, systemic inflammation is one of the most likely protagonists of this connection, as atherosclerosis is directly associated with inflammation. Finally, the aim of this review is to assess the prevalence of cardiovascular comorbidities on COPD patients, to detect the possible pathophysiological mechanisms and to discuss the available therapeutic options aimed at managing these comorbidities and reducing the COPD associated cardiovascular risk.


cardiac arrhythmias, cerebrovascular disease, chronic obstructive pulmonary disease, congestive heart failure, coronary artery disease, pulmonary hypertension, peripheral artery disease.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 9
Issue Number: 6
First Page: 384
Last Page: 391
Page Count: 8
DOI: 10.2174/1573398X10666140417235335
Price: $58
13th Asthma & COPD

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science